8,331 Shares in Synopsys, Inc. $SNPS Bought by Danica Pension Livsforsikringsaktieselskab

Danica Pension Livsforsikringsaktieselskab purchased a new stake in Synopsys, Inc. (NASDAQ:SNPS) in the 2nd quarter, HoldingsChannel reports. The fund purchased 8,331 shares of the semiconductor company’s stock, valued at approximately $3,716,000.

Other institutional investors have also recently bought and sold shares of the company. Danske Bank A S acquired a new position in shares of Synopsys during the second quarter valued at about $59,222,000. Diversify Advisory Services LLC acquired a new stake in shares of Synopsys in the 2nd quarter worth about $1,419,000. Wealthfront Advisers LLC acquired a new stake in shares of Synopsys in the 2nd quarter worth about $9,305,000. Deepwater Asset Management LLC bought a new position in Synopsys in the 2nd quarter valued at about $1,584,000. Finally, Meeder Advisory Services Inc. bought a new position in Synopsys in the 2nd quarter valued at about $2,167,000. Institutional investors and hedge funds own 85.47% of the company’s stock.

Insider Transactions at Synopsys

In other Synopsys news, CEO Sassine Ghazi sold 14,603 shares of Synopsys stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the sale, the chief executive officer owned 75,020 shares of the company’s stock, valued at approximately $34,431,179.20. The trade was a 16.29% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of the business’s stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the completion of the transaction, the chief financial officer owned 14,358 shares in the company, valued at approximately $6,461,387.16. The trade was a 19.12% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is currently owned by insiders.

Synopsys Stock Performance

Shares of Synopsys stock opened at $404.41 on Wednesday. The business’s fifty day simple moving average is $423.21 and its 200 day simple moving average is $441.54. The firm has a market capitalization of $77.44 billion, a P/E ratio of 93.61, a price-to-earnings-growth ratio of 2.48 and a beta of 1.23. Synopsys, Inc. has a 12 month low of $366.00 and a 12 month high of $624.82. The company has a current ratio of 1.43, a quick ratio of 1.32 and a debt-to-equity ratio of 0.33.

Synopsys (NASDAQ:SNPS) last announced its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $3.15 by $0.20. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The firm had revenue of $2.28 billion during the quarter, compared to the consensus estimate of $2.25 billion. During the same quarter in the prior year, the company earned $3.67 EPS. The business’s revenue for the quarter was up 41.9% on a year-over-year basis. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. As a group, analysts anticipate that Synopsys, Inc. will post 10.65 EPS for the current year.

Analyst Upgrades and Downgrades

A number of analysts have commented on the company. Morgan Stanley boosted their price objective on Synopsys from $480.00 to $525.00 and gave the stock an “equal weight” rating in a report on Thursday, May 28th. Rosenblatt Securities raised their target price on Synopsys from $530.00 to $575.00 and gave the company a “buy” rating in a report on Tuesday, May 26th. Zacks Research raised Synopsys from a “hold” rating to a “strong-buy” rating in a research report on Tuesday, June 30th. Benchmark assumed coverage on Synopsys in a research report on Wednesday, July 15th. They issued a “buy” rating and a $570.00 price target for the company. Finally, Piper Sandler raised shares of Synopsys from a “neutral” rating to an “overweight” rating and lifted their price objective for the stock from $450.00 to $550.00 in a report on Tuesday, June 23rd. Two research analysts have rated the stock with a Strong Buy rating, ten have given a Buy rating, five have assigned a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, Synopsys presently has a consensus rating of “Moderate Buy” and an average price target of $565.06.

About Synopsys

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.